You have 9 free searches left this month | for more free features.

City

Condition

Acute Myeloid Leukemia (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer (1)

Collaborator

Intervention

cytarabine. (1)

gemtuzumab ozogamicin (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

cytarabine.

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Acute Myeloid Leukemia Trial (Gemtuzumab Ozogamicin, cytarabine.)

Completed

Acute Myeloid Leukemia

Gemtuzumab Ozogamicin
cytarabine.

(no location specified)

Feb 11, 2013